Sarah Glass | Chief Operating Officer
n-Lorem Foundation

Sarah Glass, Chief Operating Officer, n-Lorem Foundation

Dr. Sarah Glass is the Chief Operating Officer of n-Lorem Foundation. Sarah received her Ph.D. in Molecular Genetics at Ohio State University where she trained in rare inherited cancer syndromes. She has over 20 years of experience in clinical development and research across academia, pharmaceutical companies, and CROs. Sarah brings significant strengths and experience as an accomplished research geneticist, rare disease drug developer, and clinical trialist. She is acclaimed for forging key strategic partnerships across rare disease sectors and has driven efficiencies to decrease patient/ caregiver burden in clinical research. Most notably, Sarah combines the professional expertise and training with the perspective of a parent. This allows Sarah to not only personally understand the challenges faced by our patients and their families, but also to translate this understanding into n-Lorem’s paradigm shifting platform solution for the ultra-rare community.

Appearances:



Day 1 - World Orphan Drug Congress USA 2024 @ 08:35

Chair opening remarks

Day 1 - World Orphan Drug Congress USA 2024 @ 12:05

Sustainability of N-of-1

Day 1 - World Orphan Drug Congress USA 2024 @ 17:35

Chair closing remarks

last published: 27/Mar/24 15:36 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

 

Marketing & Press Opportunities

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com